simvastatin has been researched along with Albuminuria in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buse, JB; Craven, TE; Ismail-Beigi, F; Katz, L; Mottl, AK; Mychaleckyj, JC; Papademetriou, V; Pedley, CF; Sigal, RJ; Simmons, DL | 1 |
| Demaine, AG; Hodgkinson, AD; Millward, BA; Shaw, NA; Yang, B | 1 |
| Li, C; Li, Y; Liu, X; Lou, T; Luo, P; Peng, H; Wang, C; Ye, Z | 1 |
| Ahlquist, P; Bagdat, D; Blegvad, J; Christensen, R; Christensen, TG; Colic, A; Ellingsen, T; Emmertsen, H; Fredberg, U; Giraldi, A; Graugaard, C; Hansen, IM; Hørslev-Petersen, K; Jensen, HS; Løgstrup, BB; Persson, F; Sheetal, E; Svendsen, L; Svensson, AL; Thygesen, T | 1 |
| Gao, Q; Jia, ZH; Li, LS; Liu, ZH; Qin, WS; Zeng, CH; Zheng, JM | 1 |
| Imig, JD; Knight, SF; Roy, S; Yuan, J | 1 |
| De Buyzere, ML; Delanghe, JR; Fiers, T; Speeckaert, MM; Wehlou, CM | 1 |
| Brizzi, P; Maioli, M; Melis, MG; Secchi, G; Tonolo, G | 1 |
| Cao, Z; Cooper, ME; Hu, L; Liu, J; Qin, J; Sun, L; Zhang, Z | 1 |
| Kiselevich, A; London, D; Magen, E; Priluk, R; Viskoper, RJ; Volchek, L; Yosefy, C | 1 |
| Hu, Y; Lin, F; Shen, H; Zhou, J; Zhu, B | 1 |
| Dellê, H; Fujihara, CK; Malheiros, DM; Mantovani, E; Mattar, AL; Noronha, IL; Rodrigues, LT; Vieira, JM; Zatz, R | 1 |
| Abaterusso, C; Abhyankar, A; Brocco, E; Carraro, A; Faedda, R; Luthman, H; Morgia, G; Nosadini, R; Satta, A; Tonolo, G; Velussi, M | 1 |
| Dollerup, J; Gormsen, LC; Mogensen, CE; Nellemann, B; Nielsen, S; Rasmussen, LM; Schmitz, O | 1 |
| Delbosc, S; Jover, B; Mimran, A; Rugale, C | 1 |
| Alberti, KG; Klausen, IC; Mogensen, CE; Møller, N; Nielsen, S; Pørksen, N; Schmitz, O | 1 |
| Miura, Y; Nakano, H; Nishimura, M; Sakai, O; Shibasaki, T; Suzuki, S; Tuchida, H; Wakabayashi, Y; Yamada, K | 1 |
| Atzeni, MM; Brizzi, P; Calvia, P; Ciccarese, M; Maioli, M; Melis, MG; Puddu, L; Secchi, G; Tonolo, G | 1 |
| Angius, MF; Brizzi, P; Carboni, A; Cherchi, GM; Ciccarese, M; Formato, M; Maioli, M; Melis, MG; Tonolo, G | 1 |
| Andersen, P; Dyerberg, J; Gall, MA; Hommel, E; Jensen, B; Nielsen, F; Parving, HH; Rossing, P | 1 |
| Moorhead, JF; Thomas, M | 1 |
| Delanghe, J; Deslypere, JP; Vermeulen, A | 1 |
9 trial(s) available for simvastatin and Albuminuria
| Article | Year |
|---|---|
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fenofibrate; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Simvastatin; Time Factors | 2018 |
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Denmark; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Severity of Illness Index; Simvastatin; Young Adult | 2016 |
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.
Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cholesterol, LDL; Cilazapril; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Endothelial Cells; Endothelium, Vascular; Evoked Potentials; Female; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Kidney; Male; Rosiglitazone; Simvastatin; Skin Physiological Phenomena; Sympathetic Nervous System; Thiazolidinediones; Time Factors; Ultrasonography; Vasodilation | 2004 |
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albumins; Albuminuria; Anticholesteremic Agents; Cholestyramine Resin; Deoxyguanosine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Lipids; Male; Middle Aged; Podocytes; Proteins; RNA, Messenger; Simvastatin | 2006 |
Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
Topics: Albuminuria; Atherosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteoprotegerin; Simvastatin | 2007 |
Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Topics: Aged; Albuminuria; Anticholesteremic Agents; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Intake; Female; Fructosamine; Glomerular Filtration Rate; Glycated Hemoglobin; Hexosamines; Humans; Hypercholesterolemia; Insulin; Kidney; Lovastatin; Male; Placebos; Simvastatin; Time Factors | 1993 |
Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment.
Topics: Adult; Aged; Albuminuria; Anticholesteremic Agents; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lipids; Male; Middle Aged; Simvastatin; Time Factors | 1997 |
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.
Topics: Albuminuria; Anticholesteremic Agents; Apolipoproteins; Blood Pressure; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 2; Female; Glycosaminoglycans; Humans; Hypertension; Male; Middle Aged; Nitrates; Nitrites; Simvastatin | 2000 |
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Topics: Adult; Albuminuria; Analysis of Variance; Apolipoproteins; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Lovastatin; Male; Simvastatin; Triglycerides | 1992 |
13 other study(ies) available for simvastatin and Albuminuria
| Article | Year |
|---|---|
Protective effect of statin therapy on connective tissue growth factor induction by diabetes in vivo and high glucose in vitro.
Topics: Albuminuria; Biomarkers; Cell Line, Transformed; Connective Tissue Growth Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression Regulation; Glomerular Mesangium; Glucose; HEK293 Cells; Humans; Luciferases, Renilla; Promoter Regions, Genetic; Simvastatin; Transcription, Genetic; Transfection | 2013 |
Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Topics: Albuminuria; Animals; Cell Line; Cell Membrane Permeability; Diabetic Nephropathies; Endothelial Cells; Gene Expression Regulation; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Glomerulus; Mice; Mice, Transgenic; Occludin; Rats; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; Tight Junctions; Zonula Occludens-1 Protein | 2013 |
Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.
Topics: Albuminuria; Animals; Anthraquinones; Anticholesteremic Agents; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Dyslipidemias; Extracellular Matrix; Fibronectins; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Phytotherapy; Rheum; Rhizome; Simvastatin; Transforming Growth Factor beta1 | 2010 |
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.
Topics: Albuminuria; Animals; Antioxidants; Cholesterol; Cyclic N-Oxides; Dietary Fats; Disease Models, Animal; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Obesity; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Risk Factors; Simvastatin; Spin Labels | 2010 |
α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients.
Topics: Adolescent; Adult; Aged; Albuminuria; Alpha-Globulins; Case-Control Studies; Cholesterol; Creatinine; Cystatin C; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Tubules; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2013 |
About the pleiotropic effects of statins in human.
Topics: Albuminuria; Blood Pressure; Cholesterol, LDL; Diabetes Mellitus, Type 2; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2003 |
Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Losartan; Male; Rats; Rats, Wistar; Simvastatin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2003 |
Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Catalase; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glutathione Transferase; Hypolipidemic Agents; Kidney Glomerulus; Lipid Peroxidation; Male; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase; Triglycerides | 2005 |
Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
Topics: Albuminuria; Animals; Cell Division; Chemokine CCL2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Lymphocytes; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA, Messenger; Simvastatin; Sodium Chloride; Transforming Growth Factor beta | 2005 |
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
Topics: Acetophenones; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Carotid Arteries; Cyclic N-Oxides; Hydralazine; Hypertension; Hypolipidemic Agents; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin; Spin Labels; Superoxides; Tunica Media | 2007 |
[Effect of hypercholesteremia on vascular endothelial function and albumin excretion rate in patients with diabetes mellitus].
Topics: Albuminuria; Anticholesteremic Agents; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin; Tissue Plasminogen Activator; von Willebrand Factor | 1996 |
Nephrotic syndrome and simvastatin.
Topics: Albuminuria; Anticholesteremic Agents; Follow-Up Studies; Humans; Lovastatin; Nephrotic Syndrome; Simvastatin | 1990 |
Proteinuria as complication of simvastatin treatment.
Topics: Albuminuria; Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Proteinuria; Simvastatin; Transferrin | 1990 |